CRI Logo
  • Alicia Zhou

    Media Room Article

    Cancer Research Institute (CRI) Appoints Alicia Zhou, PhD, as Chief Executive Officer to Advance Next Generation of Cancer Immunotherapy Science and Innovation

    NEW YORK, NY — The Cancer Research Institute (CRI), the preeminent nonprofit organization focused on advancing breakthroughs…
    septiembre 9, 2024
  • Media Room Article

    Global Experts Converge at CICON24 to Unveil Groundbreaking Advances in Cancer Immunotherapy, September 8-11, 2024 at National Harbor, MD

    NATIONAL HARBOR, MD – The Cancer Research Institute (CRI) and the European Network for Cancer Immunotherapy (ENCI)…
    septiembre 6, 2024
  • Media Room Article

    The 2024 Impact Report of the Cancer Research Institute

    Executive Summary   Since our founding in 1953, the Cancer Research Institute (CRI) has been at the forefront…
    agosto 9, 2024
  • Media Room Article

    Cancer Research Institute Awards Over $22 Million in Grants to Fuel Immunotherapy Innovations

    NEW YORK – August 8, 2024 — As the leading nonprofit organization committed to revolutionizing cancer treatment…
    agosto 8, 2024
  • Media Room Article

    Cancer Research Institute Announces New Lloyd J. Old STARs Class

    New York, NY – August 5, 2024 – The Cancer Research Institute (CRI) proudly announces the newest…
    agosto 5, 2024
  • Media Room Article

    Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics’ ENB-003 for the Treatment of Ovarian Cancer

    REDWOOD CITY, Calif., May 8, 2024 — Coherus BioSciences, Inc. (Coherus; Nasdaq: CHRS) today announced that the…
    mayo 8, 2024
  • Media Room Article

    New Survey of U.S. Oncologists Reveals Where More Work Can Be Done to Research Treatments for Advanced Non-Small Cell Lung Cancer

    Survey examined oncologists’ perspective on treatment options and priorities, comorbidities and other clinical characteristics of patients with…
    enero 24, 2024
  • Media Room Article

    CRI CEO and Director of Scientific Affairs Dr. Jill O’Donnell-Tormey on Immunotherapy and Her Tenure

    NEW YORK – Jill O’Donnell-Tormey, PhD, CEO and director of scientific affairs at the Cancer Research Institute…
    diciembre 21, 2023
  • Media Room Article

    Cancer Research Institute Joins Lance Kawaguchi, #SouthPoleTrek4Cancer to Ring the Nasdaq Stock Market Closing Bell

    Contact: Melinda Koski, SouthPoleTrek4Cancer Sharon Slade, Chief Marketing Officer, CRI For Immediate Release Tuesday, December 19, 2023…
    diciembre 19, 2023

© 2025 Cancer Research Institute. All Trademarks referred to are the property of their respective owners.